Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ravit Boger MD

Ravit Boger MD profile photo picture

Chief, Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Infectious Disease

Member of the Center for Immunology
Member of the Center for Microbiome Research

Publications (92)

  • Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors. (Trevisan M, Pianezzola A, Onorati M, Apolloni L, Pistello M, Arav-Boger R, Palù G, Mercorelli B, Loregian A) Antiviral Res 2024 Mar;223:105816 PMID: 38286212 SCOPUS ID: 2-s2.0-85184485404 01/30/2024    
  • Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients. (Shapira G, Volkov H, Fabian I, Mohr DW, Bettinotti M, Shomron N, Avery RK, Arav-Boger R) Viruses 2023 Nov 08;15(11) PMID: 38005904 PMCID: PMC10674338 SCOPUS ID: 2-s2.0-85177737555 11/25/2023    
  • Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control. (Ghosh AK, Su YP, Forman M, Keyes RF, Smith BC, Hu X, Ferrer M, Arav-Boger R) J Virol 2023 Apr 27;97(4):e0016023 PMID: 36939350 PMCID: PMC10134830 SCOPUS ID: 2-s2.0-85159161803 03/21/2023       1 Citation
  • Correction: Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization. (Holdhoff M, Guner G, Rodriguez FJ, Hicks JL, Zheng Q, Forman MS, Ye X, Grossman SA, Meeker AK, Heaphy CM, Eberhart CG, De Marzo AM, Arav-Boger R) Clin Cancer Res 2022 Apr 14;28(8):1737 PMID: 35419593 SCOPUS ID: 2-s2.0-85128329131 04/15/2022    
  • The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides. (Guo X, Ghosh AK, Keyes RF, Peterson F, Forman M, Meyers DJ, Arav-Boger R) Viruses 2022 Jan 25;14(2) PMID: 35215828 PMCID: PMC8876412 SCOPUS ID: 2-s2.0-85123542102 02/27/2022       1 Citation
  • The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides (Guo X, Ghosh AK, Keyes RF, Peterson F, Forman M, Meyers DJ, Arav-Boger R) Viruses February 2022;14(2) SCOPUS ID: 2-s2.0-85123542102 02/01/2022       1 Citation
  • T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice. (Li M, Garforth SJ, O'Connor KE, Su H, Lee DM, Celikgil A, Chaparro RJ, Seidel RD, Jones RB, Arav-Boger R, Almo SC, Goldstein H) J Clin Invest 2021 Dec 01;131(23) PMID: 34673568 PMCID: PMC8631598 SCOPUS ID: 2-s2.0-85121153546 10/22/2021       12 Citations
  • A Novel Multiplexed Enzyme-Linked Immunosorbent Assay for the Detection of IgG Seroreactivity to Cytomegalovirus (CMV) UL144. (Miller H, Simpson P, Forman M, Prigan A, Kehl S, Mesich B, Faron M, Ledeboer N, Arav-Boger R) J Clin Microbiol 2021 Jul 19;59(8):e0096421 PMID: 34076473 PMCID: PMC8373222 SCOPUS ID: 2-s2.0-85112127278 06/03/2021       2 Citations
  • Inhibition of Human Coronaviruses by Antimalarial Peroxides. (Ghosh AK, Miller H, Knox K, Kundu M, Henrickson KJ, Arav-Boger R) ACS Infect Dis 2021 Jul 09;7(7):1985-1995 PMID: 33783182 SCOPUS ID: 2-s2.0-85105043981 03/31/2021       22 Citations
  • Antiviral Effects of Oleandrin. (Newman RA, Sastry KJ, Arav-Boger R, Cai H, Matos R, Harrod R) J Exp Pharmacol 2020;12:503-515 PMID: 33262663 PMCID: PMC7686471 SCOPUS ID: 2-s2.0-85097879623 12/03/2020       17 Citations
  • Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection. (Mehta Steinke SA, Alfares M, Valsamakis A, Shoham S, Arav-Boger R, Lees L, Ostrander D, Forman MS, Shedeck A, Ambinder RF, Jones RJ, Avery RK) Transpl Infect Dis 2021 Jun;23(3):e13521 PMID: 33220125 PMCID: PMC9353742 SCOPUS ID: 2-s2.0-85097027320 11/22/2020       21 Citations
  • Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition. (Roy S, Kapoor A, Zhu F, Mukhopadhyay R, Ghosh AK, Lee H, Mazzone J, Posner GH, Arav-Boger R) J Biol Chem 2020 Oct 30;295(44):15013-15028 PMID: 32855235 PMCID: PMC7606667 SCOPUS ID: 2-s2.0-85094983683 08/29/2020       14 Citations
  • Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus. (Kapoor A, Ghosh AK, Forman M, Hu X, Ye W, Southall N, Marugan J, Keyes RF, Smith BC, Meyers DJ, Ferrer M, Arav-Boger R) J Med Chem 2020 Apr 23;63(8):3896-3907 PMID: 32191456 PMCID: PMC7386824 SCOPUS ID: 2-s2.0-85084027851 03/20/2020       8 Citations
  • Platelet-endothelial associations may promote cytomegalovirus replication in the salivary gland in mice. (Braxton AM, Chalmin AL, Najarro KM, Brockhurst JK, Johnson KT, Lyons CE, Daly B, Cryer CG, Vijay S, Cyphers G, Guerrero-Martin SM, Aston SA, McGee K, Su YP, Arav-Boger R, Metcalf Pate KA) Platelets 2020 Oct 02;31(7):860-868 PMID: 31726921 PMCID: PMC7220825 SCOPUS ID: 2-s2.0-85075182495 11/16/2019    
  • Acute HIV in an Adolescent Male With Fever and Rhabdomyolysis. (Same RG, McAleese S, Agwu AL, Arav-Boger R) J Adolesc Health 2019 Oct;65(4):567-569 PMID: 31401024 PMCID: PMC7004276 SCOPUS ID: 2-s2.0-85071999417 08/12/2019       1 Citation
  • Prevalence, Magnitude, and Genotype Distribution of Urinary Cytomegalovirus (CMV) Shedding Among CMV-Seropositive Children and Adolescents in the United States. (White JL, Patel EU, Abraham AG, Grabowski MK, Arav-Boger R, Avery RK, Quinn TC, Tobian AAR) Open Forum Infect Dis 2019 Jul;6(7):ofz272 PMID: 31281866 PMCID: PMC6602884 SCOPUS ID: 2-s2.0-85084262945 07/10/2019       5 Citations
  • Evaluating congenital syphilis in a reverse sequence testing environment. (Chen MW, Akinboyo IC, Sue PK, Donohue PK, Ghanem KG, Detrick B, Witter FR, Page KR, Arav-Boger R, Golden WC) J Perinatol 2019 Jul;39(7):956-963 PMID: 31076626 SCOPUS ID: 2-s2.0-85065649696 05/12/2019       3 Citations
  • Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings. (Jackson JW, Hancock TJ, Dogra P, Patel R, Arav-Boger R, Williams AD, Kennel SJ, Wall JS, Sparer TE) mSphere 2019 Feb 13;4(1) PMID: 30760613 PMCID: PMC6374593 SCOPUS ID: 2-s2.0-85061598833 02/15/2019       8 Citations
  • Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection. (Marsico C, Aban I, Kuo H, James SH, Sanchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth S, Jester PM, Whitley RJ, Kimberlin DW, Collaborative Antiviral Study Group (CASG)) J Infect Dis 2019 Apr 16;219(9):1398-1406 PMID: 30535363 PMCID: PMC6467187 SCOPUS ID: 2-s2.0-85064994989 12/12/2018       35 Citations
  • Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees. (Nelson CS, Vera Cruz D, Su M, Xie G, Vandergrift N, Pass RF, Forman M, Diener-West M, Koelle K, Arav-Boger R, Permar SR) J Virol 2019 Mar 01;93(5) PMID: 30518646 PMCID: PMC6384057 SCOPUS ID: 2-s2.0-85061846796 12/07/2018       17 Citations
  • Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides. (Wang Y, Mukhopadhyay R, Roy S, Kapoor A, Su YP, Charman SA, Chen G, Wu J, Wang X, Vennerstrom JL, Arav-Boger R) Antimicrob Agents Chemother 2019 Jan;63(1) PMID: 30373792 PMCID: PMC6325236 SCOPUS ID: 2-s2.0-85058920560 10/31/2018       12 Citations
  • Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention. (Pass RF, Arav-Boger R) F1000Res 2018;7:255 PMID: 29560263 PMCID: PMC5832908 SCOPUS ID: 2-s2.0-85043322806 03/22/2018       62 Citations
  • A 17-Year-Old Boy With Right Face Palsy, Left Leg Weakness, and Lytic Skull-Bone Lesions. (Akinboyo IC, Crane GM, Chen L, Arav-Boger R) J Pediatric Infect Dis Soc 2018 Dec 03;7(4):350-354 PMID: 29373673 PMCID: PMC6276027 SCOPUS ID: 2-s2.0-85058750832 01/27/2018       2 Citations
  • Digitoxin Suppresses Human Cytomegalovirus Replication via Na+, K+/ATPase α1 Subunit-Dependent AMP-Activated Protein Kinase and Autophagy Activation. (Mukhopadhyay R, Venkatadri R, Katsnelson J, Arav-Boger R) J Virol 2018 Mar 15;92(6) PMID: 29321306 PMCID: PMC5827378 SCOPUS ID: 2-s2.0-85042487844 01/13/2018       27 Citations
  • Cytomegalovirus infections (Gontasz MM, Arav-Boger R) The 5-Minute Pediatric Consult, 8th Edition 1 January 2018:260-261 SCOPUS ID: 2-s2.0-85059392388 01/01/2018    
  • Placental pericytes and cytomegalovirus infectivity: Implications for HCMV placental pathology and congenital disease. (Aronoff DM, Correa H, Rogers LM, Arav-Boger R, Alcendor DJ) Am J Reprod Immunol 2017 Sep;78(3) PMID: 28741727 PMCID: PMC5561471 SCOPUS ID: 2-s2.0-85026411248 07/26/2017       18 Citations
  • The effect of a genetic variant on quantitative real-time PCR in a case of disseminated adenovirus infection. (Gniadek TJ, Forman MT, Martin I, Arav-Boger R, Valsamakis A) Diagn Microbiol Infect Dis 2017 Sep;89(1):40-43 PMID: 28629877 SCOPUS ID: 2-s2.0-85020783915 06/21/2017       3 Citations
  • Cytomegalovirus Kinetics Following Primary Infection in Healthy Women. (Forman MS, Vaidya D, Bolorunduro O, Diener-West M, Pass RF, Arav-Boger R) J Infect Dis 2017 May 15;215(10):1523-1526 PMID: 28431127 PMCID: PMC5461424 SCOPUS ID: 2-s2.0-85021829857 04/22/2017       16 Citations
  • Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization. (Cui X, Adler SP, Schleiss MR, Arav-Boger R, Demmler Harrison GJ, McVoy MA) Clin Vaccine Immunol 2017 Jun;24(6) PMID: 28404573 PMCID: PMC5461377 SCOPUS ID: 2-s2.0-85020190703 04/14/2017       7 Citations
  • Is drug repurposing the answer for cytomegalovirus treatment or prevention? (Arav-Boger R) Future Virology March 2017;12(3):103-109 SCOPUS ID: 2-s2.0-85014858303 03/01/2017    
  • Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization. (Holdhoff M, Guner G, Rodriguez FJ, Hicks JL, Zheng Q, Forman MS, Ye X, Grossman SA, Meeker AK, Heaphy CM, Eberhart CG, De Marzo AM, Arav-Boger R) Clin Cancer Res 2017 Jun 15;23(12):3150-3157 PMID: 28034905 PMCID: PMC5474132 SCOPUS ID: 2-s2.0-85020897283 12/31/2016       47 Citations
  • Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo. (Fan YH, Roy S, Mukhopadhyay R, Kapoor A, Duggal P, Wojcik GL, Pass RF, Arav-Boger R) Proc Natl Acad Sci U S A 2016 Nov 29;113(48):E7818-E7827 PMID: 27856764 PMCID: PMC5137695 SCOPUS ID: 2-s2.0-84999154631 11/20/2016       30 Citations
  • Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection. (Avery RK, Arav-Boger R, Marr KA, Kraus E, Shoham S, Lees L, Trollinger B, Shah P, Ambinder R, Neofytos D, Ostrander D, Forman M, Valsamakis A) Transplantation 2016 Oct;100(10):e74-80 PMID: 27495775 PMCID: PMC5030152 SCOPUS ID: 2-s2.0-84982840819 08/09/2016       122 Citations
  • Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus. (Mukhopadhyay R, Roy S, Venkatadri R, Su YP, Ye W, Barnaeva E, Mathews Griner L, Southall N, Hu X, Wang AQ, Xu X, Dulcey AE, Marugan JJ, Ferrer M, Arav-Boger R) PLoS Pathog 2016 Jun;12(6):e1005717 PMID: 27336364 PMCID: PMC4919066 SCOPUS ID: 2-s2.0-84978880831 06/24/2016       51 Citations
  • Effect of artemether-lumefantrine (Coartem) on cytomegalovirus urine viral load during and following treatment for malaria in children. (Barger-Kamate B, Forman M, Sangare CO, Haidara AS, Maiga H, Vaidya D, Djimde A, Arav-Boger R) J Clin Virol 2016 Apr;77:40-5 PMID: 26895228 PMCID: PMC4792724 SCOPUS ID: 2-s2.0-84960400714 02/20/2016       15 Citations
  • Cytomegalovirus Enterocolitis in Immunocompetent Young Children: A Report of Two Cases and Review of the Literature. (Sue PK, Salazar-Austin NM, McDonald OG, Rishi A, Cornish TC, Arav-Boger R) Pediatr Infect Dis J 2016 May;35(5):573-6 PMID: 26862673 PMCID: PMC4829454 SCOPUS ID: 2-s2.0-84957824110 02/11/2016       15 Citations
  • Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway. (Kapoor A, Fan YH, Arav-Boger R) Sci Rep 2016 Feb 02;6:20295 PMID: 26830977 PMCID: PMC4735818 SCOPUS ID: 2-s2.0-84957566003 02/03/2016       19 Citations
  • Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. (Fox JM, Moynihan JR, Mott BT, Mazzone JR, Anders NM, Brown PA, Rudek MA, Liu JO, Arav-Boger R, Posner GH, Civin CI, Chen X) Oncotarget 2016 Feb 09;7(6):7268-79 PMID: 26771236 PMCID: PMC4872784 SCOPUS ID: 2-s2.0-84980701332 01/16/2016       25 Citations
  • Human Cytomegalovirus Inhibits the PARsylation Activity of Tankyrase--A Potential Strategy for Suppression of the Wnt Pathway. (Roy S, Liu F, Arav-Boger R) Viruses 2015 Dec 29;8(1) PMID: 26729153 PMCID: PMC4728568 SCOPUS ID: 2-s2.0-84952838065 01/06/2016       14 Citations
  • Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease (Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, DeBiasi RL, Han JY, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths PD, Luck S, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Woods CR, Sabo DL, Aban I, Kuo H, James SH, Prichard MN, Griffin J, Giles D, Acosta EP, Whitley RJ) Obstetrical and Gynecological Survey 29 August 2015;70(8):489-490 SCOPUS ID: 2-s2.0-84940531652 08/29/2015       1 Citation
  • Strain Variation and Disease Severity in Congenital Cytomegalovirus Infection: In Search of a Viral Marker. (Arav-Boger R) Infect Dis Clin North Am 2015 Sep;29(3):401-14 PMID: 26154664 PMCID: PMC4552582 SCOPUS ID: 2-s2.0-84952876265 07/15/2015       30 Citations
  • Broad-spectrum non-nucleoside inhibitors of human herpesviruses. (McClain L, Zhi Y, Cheng H, Ghosh A, Piazza P, Yee MB, Kumar S, Milosevic J, Bloom DC, Arav-Boger R, Kinchington PR, Yolken R, Nimgaonkar V, D'Aiuto L) Antiviral Res 2015 Sep;121:16-23 PMID: 26079681 PMCID: PMC4536133 SCOPUS ID: 2-s2.0-84933565947 06/17/2015       19 Citations
  • Autoinduction of voriconazole metabolism in a child with invasive pulmonary aspergillosis. (Hsu AJ, Dabb A, Arav-Boger R) Pharmacotherapy 2015 Apr;35(4):e20-6 PMID: 25884532 SCOPUS ID: 2-s2.0-84927757197 04/18/2015       18 Citations
  • Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation. (Roy S, He R, Kapoor A, Forman M, Mazzone JR, Posner GH, Arav-Boger R) Antimicrob Agents Chemother 2015 Jul;59(7):3870-9 PMID: 25870074 PMCID: PMC4468661 SCOPUS ID: 2-s2.0-84935830286 04/15/2015       32 Citations
  • Valganciclovir for symptomatic congenital cytomegalovirus disease. (Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, Ashouri N, Englund JA, Estrada B, Jacobs RF, Romero JR, Sood SK, Whitworth MS, Abzug MJ, Caserta MT, Fowler S, Lujan-Zilbermann J, Storch GA, DeBiasi RL, Han JY, Palmer A, Weiner LB, Bocchini JA, Dennehy PH, Finn A, Griffiths PD, Luck S, Gutierrez K, Halasa N, Homans J, Shane AL, Sharland M, Simonsen K, Vanchiere JA, Woods CR, Sabo DL, Aban I, Kuo H, James SH, Prichard MN, Griffin J, Giles D, Acosta EP, Whitley RJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group) N Engl J Med 2015 Mar 05;372(10):933-43 PMID: 25738669 PMCID: PMC4401811 SCOPUS ID: 2-s2.0-84924452538 03/05/2015       542 Citations
  • Digitoxin analogues with improved anticytomegalovirus activity. (Cai H, Wang HY, Venkatadri R, Fu DX, Forman M, Bajaj SO, Li H, O'Doherty GA, Arav-Boger R) ACS Med Chem Lett 2014 Apr 10;5(4):395-9 PMID: 24900847 PMCID: PMC4027591 SCOPUS ID: 2-s2.0-84898034560 06/06/2014       39 Citations
  • New cell-signaling pathways for controlling cytomegalovirus replication. (Roy S, Arav-Boger R) Am J Transplant 2014 Jun;14(6):1249-58 PMID: 24839861 PMCID: PMC4280670 SCOPUS ID: 2-s2.0-84901363363 05/21/2014       23 Citations
  • Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication. (Kapoor A, Forman M, Arav-Boger R) PLoS One 2014;9(3):e92704 PMID: 24671169 PMCID: PMC3966837 SCOPUS ID: 2-s2.0-84899922475 03/29/2014       46 Citations
  • Erratum: Human Induced Pluripotent Stem Cell-Derived Models to Investigate Human Cytomegalovirus Infection in Neural Cells (PLoS ONE (2014) 9:1 (DOI:10.1371/annotation/ea66e8f1-9f80-422f-8836-308a4cdc8ae4)) (D'Aiuto L, Di Maio R, Heath B, Raimondi G, Milosevic J, Watson AM, Bamne M, Parks WT, Yang L, Lin B, Miki T, Mich-Basso JD, Arav-Boger R, Sibille E, Sabunciyan S, Yolken R, Nimgaonkar V) PLoS ONE 2 January 2014;9(1) SCOPUS ID: 2-s2.0-84895474557 01/02/2014    
  • In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action. (Cai H, Kapoor A, He R, Venkatadri R, Forman M, Posner GH, Arav-Boger R) Antimicrob Agents Chemother 2014;58(2):986-94 PMID: 24277030 PMCID: PMC3910867 SCOPUS ID: 2-s2.0-84893460790 11/28/2013       50 Citations
  • Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety. (He R, Forman M, Mott BT, Venkatadri R, Posner GH, Arav-Boger R) Antimicrob Agents Chemother 2013 Sep;57(9):4208-14 PMID: 23774439 PMCID: PMC3754318 SCOPUS ID: 2-s2.0-84882367844 06/19/2013       28 Citations
  • Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study. (Mott BT, He R, Chen X, Fox JM, Civin CI, Arav-Boger R, Posner GH) Bioorg Med Chem 2013 Jul 01;21(13):3702-7 PMID: 23673218 PMCID: PMC3685872 SCOPUS ID: 2-s2.0-84878563527 05/16/2013       36 Citations
  • Wnt modulating agents inhibit human cytomegalovirus replication. (Kapoor A, He R, Venkatadri R, Forman M, Arav-Boger R) Antimicrob Agents Chemother 2013 Jun;57(6):2761-7 PMID: 23571549 PMCID: PMC3716142 SCOPUS ID: 2-s2.0-84877863281 04/11/2013       44 Citations
  • Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. (D'Aiuto L, Di Maio R, Heath B, Raimondi G, Milosevic J, Watson AM, Bamne M, Parks WT, Yang L, Lin B, Miki T, Mich-Basso JD, Arav-Boger R, Sibille E, Sabunciyan S, Yolken R, Nimgaonkar V) PLoS One 2012;7(11):e49700 PMID: 23209593 PMCID: PMC3507916 SCOPUS ID: 2-s2.0-84870274844 12/05/2012       60 Citations
  • Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene. (Kapoor A, Cai H, Forman M, He R, Shamay M, Arav-Boger R) Antimicrob Agents Chemother 2012 Sep;56(9):4891-9 PMID: 22777050 PMCID: PMC3421849 SCOPUS ID: 2-s2.0-84865426387 07/11/2012       46 Citations
  • Dried urine spots for detection and quantification of cytomegalovirus in newborns. (Forman M, Valsamakis A, Arav-Boger R) Diagn Microbiol Infect Dis 2012 Aug;73(4):326-9 PMID: 22658885 PMCID: PMC3396794 SCOPUS ID: 2-s2.0-84863778488 06/05/2012       19 Citations
  • Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication. (He R, Park K, Cai H, Kapoor A, Forman M, Mott B, Posner GH, Arav-Boger R) Antimicrob Agents Chemother 2012 Jul;56(7):3508-15 PMID: 22547612 PMCID: PMC3393438 SCOPUS ID: 2-s2.0-84862564807 05/02/2012       36 Citations
  • Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine. (Arav-Boger R, Wojcik GL, Duggal P, Ingersoll RG, Beaty T, Pass RF, Yolken RH) BMC Res Notes 2012 Mar 13;5:140 PMID: 22414065 PMCID: PMC3317442 SCOPUS ID: 2-s2.0-84857929332 03/15/2012       24 Citations
  • An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities. (He R, Mott BT, Rosenthal AS, Genna DT, Posner GH, Arav-Boger R) PLoS One 2011;6(8):e24334 PMID: 21904628 PMCID: PMC3164168 SCOPUS ID: 2-s2.0-80052337277 09/10/2011       60 Citations
  • Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors. (He R, Sandford G, Hayward GS, Burns WH, Posner GH, Forman M, Arav-Boger R) Virol J 2011 Jan 26;8:40 PMID: 21269468 PMCID: PMC3041771 SCOPUS ID: 2-s2.0-79251535312 01/29/2011       34 Citations
  • Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women. (Murthy S, Hayward GS, Wheelan S, Forman MS, Ahn JH, Pass RF, Arav-Boger R) PLoS One 2011 Jan 10;6(1):e15949 PMID: 21264339 PMCID: PMC3018470 SCOPUS ID: 2-s2.0-79251582817 01/26/2011       25 Citations
  • Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers. (Arav-Boger R, He R, Chiou CJ, Liu J, Woodard L, Rosenthal A, Jones-Brando L, Forman M, Posner G) PLoS One 2010 Apr 28;5(4):e10370 PMID: 20442781 PMCID: PMC2860993 SCOPUS ID: 2-s2.0-77956397844 05/06/2010       53 Citations
  • Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. (Jacobson LM, Milstone AM, Zenilman J, Carroll KC, Arav-Boger R) Pediatr Infect Dis J 2009 May;28(5):445-7 PMID: 19295462 SCOPUS ID: 2-s2.0-67649531477 03/20/2009       16 Citations
  • Treatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishments. (Arav-Boger R) Virus Genes 2009 Apr;38(2):195-203 PMID: 19139983 SCOPUS ID: 2-s2.0-61849139074 01/14/2009       11 Citations
  • The use of artificial neural networks in prediction of congenital CMV outcome from sequence data. (Arav-Boger R, Boger YS, Foster CB, Boger Z) Bioinform Biol Insights 2008 May 29;2:281-9 PMID: 19812782 PMCID: PMC2735958 01/01/2008    
  • Viral load in congenital cytomegalovirus infection. (Arav-Boger R, Pass R) Herpes 2007 Jun;14(1):17-22 PMID: 17848214 SCOPUS ID: 2-s2.0-34547799573 09/13/2007       8 Citations
  • Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes. (Zong JC, Arav-Boger R, Alcendor DJ, Hayward GS) J Clin Virol 2007 Sep;40(1):1-8 PMID: 17698410 PMCID: PMC2084348 SCOPUS ID: 2-s2.0-34548147060 08/19/2007       19 Citations
  • Shwachman--Diamond syndrome associated with autoimmune phenomena. (Reif S, Arav-Boger R, Diamant S, Burstein Y, Fatal A) J Med 1999;30(3-4):259-65 PMID: 17312679 SCOPUS ID: 2-s2.0-0033510371 02/23/2007       3 Citations
  • Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. (Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS, Diener-West M, Landini MP) J Infect Dis 2006 Aug 15;194(4):464-73 PMID: 16845629 SCOPUS ID: 2-s2.0-33746739445 07/18/2006       55 Citations
  • Human cytomegalovirus-encoded alpha -chemokines exhibit high sequence variability in congenitally infected newborns. (Arav-Boger R, Foster CB, Zong JC, Pass RF) J Infect Dis 2006 Mar 15;193(6):788-91 PMID: 16479512 SCOPUS ID: 2-s2.0-33644900710 02/16/2006       44 Citations
  • Loss of linkage disequilibrium and accelerated protein divergence in duplicated cytomegalovirus chemokine genes. (Arav-Boger R, Zong JC, Foster CB) Virus Genes 2005 Aug;31(1):65-72 PMID: 15965610 SCOPUS ID: 2-s2.0-21244483578 06/21/2005       21 Citations
  • Molecular mechanisms of resistance in antimalarial chemotherapy: the unmet challenge. (Arav-Boger R, Shapiro TA) Annu Rev Pharmacol Toxicol 2005;45:565-85 PMID: 15822189 SCOPUS ID: 2-s2.0-13844319811 04/12/2005       48 Citations
  • Diagnosis and management of cytomegalovirus infection in the newborn. (Arav-Boger R, Pass RF) Pediatr Ann 2002 Nov;31(11):719-25 PMID: 12455480 SCOPUS ID: 2-s2.0-0036847305 11/29/2002       10 Citations
  • Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. (Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D, Hayward GS) J Infect Dis 2002 Oct 15;186(8):1057-64 PMID: 12355354 SCOPUS ID: 2-s2.0-0037108926 10/02/2002       99 Citations
  • Cerebellar ataxia as the presenting manifestation of Lyme disease. (Arav-Boger R, Crawford T, Steere AC, Halsey NA) Pediatr Infect Dis J 2002 Apr;21(4):353-6 PMID: 12075773 SCOPUS ID: 2-s2.0-0036229462 06/22/2002       19 Citations
  • Leukocytosis caused by prostaglandin E1 in neonates. (Arav-Boger R, Baggett HC, Spevak PJ, Willoughby RE) J Pediatr 2001 Feb;138(2):263-5 PMID: 11174627 SCOPUS ID: 2-s2.0-0035134876 02/15/2001       17 Citations
  • Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. (Arav-Boger R, Echavarria M, Forman M, Charache P, Persaud D) Pediatr Infect Dis J 2000 Nov;19(11):1097-100 PMID: 11099095 SCOPUS ID: 2-s2.0-0033678150 12/01/2000       53 Citations
  • Cat-bite tularemia in a seventeen-year-old girl treated with ciprofloxacin. (Arav-Boger R) Pediatr Infect Dis J 2000 Jun;19(6):583-4 PMID: 10877184 SCOPUS ID: 2-s2.0-0034086531 07/06/2000       26 Citations
  • Seroprevalence of pertussis antibodies among adolescents in Israel. (Arav-Boger R, Ashkenazi S, Gdalevich M, Cohen D, Danon YL) Isr Med Assoc J 2000 Feb;2(2):174-7 PMID: 10804947 SCOPUS ID: 2-s2.0-0033839156 05/11/2000       18 Citations
  • Human monocytic ehrlichiosis in a child with leukemia. (Arav-Boger R, Knepp JH, Walls JJ, Dumler JS) Pediatr Infect Dis J 2000 Feb;19(2):173-5 PMID: 10694014 SCOPUS ID: 2-s2.0-0033952429 02/29/2000       12 Citations
  • Complications of minocycline therapy for acne vulgaris: case reports and review of the literature. (Somech R, Arav-Boger R, Assia A, Spirer Z, Jurgenson U) Pediatr Dermatol 1999;16(6):469-72 PMID: 10632948 SCOPUS ID: 2-s2.0-0033427633 01/13/2000       36 Citations
  • Periodic syndromes of childhood. (Arav-Boger R, Spirer Z) Adv Pediatr 1997;44:389-428 PMID: 9265977 SCOPUS ID: 2-s2.0-0030634280 01/01/1997       21 Citations
  • Cholestatic hepatitis as a main manifestation of Mycoplasma pneumoniae infection. (Arav-Boger R, Assia A, Spirer Z, Bujanover Y, Reif S) J Pediatr Gastroenterol Nutr 1995 Nov;21(4):459-60 PMID: 8583300 SCOPUS ID: 2-s2.0-0028824373 11/01/1995       20 Citations
  • Chronic fatigue syndrome: pediatric aspects. (Arav-Boger R, Spirer Z) Isr J Med Sci 1995 May;31(5):330-4 PMID: 7759230 SCOPUS ID: 2-s2.0-0029021649 05/01/1995       11 Citations
  • Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. (Arav-Boger R, Reif S, Bujanover Y) J Pediatr 1995 Apr;126(4):586-8 PMID: 7699538 SCOPUS ID: 2-s2.0-0028934039 04/01/1995       56 Citations
  • [Hemophilus influenzae meningitis despite vaccination]. (Jurgenson U, Asia A, Arav-Boger R) Harefuah 1994 Oct;127(7-8):231-4, 287 PMID: 7813948 SCOPUS ID: 2-s2.0-0028566584 10/01/1994       1 Citation
  • [Decreased interleukin-1 and interleukin-2 production after splenectomy]. (Spirer Z, Arav-Boger R, Zakuth V, Tzehoval E, Dagan S, Lev B, Golander A, Melamed I) Harefuah 1994 Apr 01;126(7):374-7, 426 PMID: 8200582 SCOPUS ID: 2-s2.0-0028411285 04/01/1994       2 Citations
  • Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs multiple-day treatment. (Arav-Boger R, Leibovici L, Danon YL) Arch Intern Med 1994 Feb 14;154(3):300-4 PMID: 8297196 SCOPUS ID: 2-s2.0-0028013061 02/14/1994       52 Citations
  • The immunology of Kawasaki disease. (Arav-Boger R, Assia A, Jurgenson U, Spirer Z) Adv Pediatr 1994;41:359-67 PMID: 7992690 SCOPUS ID: 2-s2.0-0028696596 01/01/1994       7 Citations
  • A clinical model for diagnosis of urinary tract infection in young women. (Leibovici L, Arav-Boger R, Danon YL) Arch Intern Med 1993 Apr 26;153(8):1011, 1015 PMID: 8481064 SCOPUS ID: 2-s2.0-0027294897 04/26/1993       4 Citations
  • Surgical closed pulmonary valvotomy for critical pulmonary stenosis: implications for the balloon valvuloplasty era. (Smolinsky A, Arav R, Hegesh J, Lusky A, Goor DA) Thorax 1992 Mar;47(3):179-83 PMID: 1519195 PMCID: PMC1021007 SCOPUS ID: 2-s2.0-0026606223 03/01/1992       8 Citations
  • Diltiazem and thrombocytopenia. (Lahav M, Arav R) Ann Intern Med 1989 Feb 15;110(4):327 PMID: 2913921 SCOPUS ID: 2-s2.0-0024551287 02/15/1989       10 Citations
  • Last update: 06/21/2024